Alignment Healthcare, Inc.

NasdaqGS:ALHC Stock Report

Market Cap: US$892.0m

Alignment Healthcare Past Earnings Performance

Past criteria checks 0/6

Alignment Healthcare's earnings have been declining at an average annual rate of -21.9%, while the Healthcare industry saw earnings growing at 5.5% annually. Revenues have been growing at an average rate of 21.3% per year.

Key information

-21.9%

Earnings growth rate

-17.3%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate21.3%
Return on equity-93.7%
Net Margin-8.1%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Feb 24
It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Jan 18
Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Nov 08
Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Alignment Healthcare: Investors Should Align Themselves With Insiders

Oct 05

Alignment Healthcare announces 9M shares secondary offering

Sep 15

Alignment Healthcare completes debt refinancing

Sep 06

Alignment Healthcare: This Next-Generation Medicare Startup Is Fully Valued

Aug 22

Alignment Health Plan plans to expand into three Nevada counties

Jul 20

Alignment Healthcare Grows Revenue But Operating Losses Remain

May 17

Earnings Release: Here's Why Analysts Cut Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$15.75

Mar 06
Earnings Release: Here's Why Analysts Cut Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$15.75

Revenue & Expenses Breakdown
Beta

How Alignment Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:ALHC Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231,824-1483060
30 Sep 231,720-1583070
30 Jun 231,624-1633000
31 Mar 231,528-1462920
31 Dec 221,434-1502960
30 Sep 221,371-1402900
30 Jun 221,304-1462910
31 Mar 221,246-1793000
31 Dec 211,168-1952910
30 Sep 211,112-1802640
30 Jun 211,066-1232260
31 Mar 211,002-701890
31 Dec 20959-231560
31 Dec 19757-451100

Quality Earnings: ALHC is currently unprofitable.

Growing Profit Margin: ALHC is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALHC is unprofitable, and losses have increased over the past 5 years at a rate of 21.9% per year.

Accelerating Growth: Unable to compare ALHC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALHC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (8%).


Return on Equity

High ROE: ALHC has a negative Return on Equity (-93.74%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.